SPOTLIGHT: Novartis sues Trimeris for patent infringement

The biopharmaceutical company Trimeris says it's being sued by Novartis for infringing a patent the Swiss drug maker got a month ago. The suit targets Fuzeon, Trimeris' HIV treatment developed in collaboration with Roche and approved in 2003. Report

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.